Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gianluca Cera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Endocrinology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Fondazione Policlinico "A. Gemelli" IR…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Hyperandrogenism, Steroid 21-Hydroxylase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive endocrine disorders characterized by alteration in adrenal hormonal secretions. The most common form is caused by CYP21A2 mutations that result in 21-hydroxylase deficiency. Clinical features can vary, from salt-wasting forms, characterized by a lack of mineralocorticoid activity with a risk of perinatal-onset adrenal crises, to “simple-virilizing” forms with sufficient aldosterone secretion, up to milder “non-classical” forms, with a variable grade of hyperandrogenism but no severe hormonal deficiencies. During pregnancy, CAH 46,XX fetuses are exposed to elevated androgen levels, leading to a variable grade of virilization and potential central nervous system effects if untreated. These patients are usually (but not always) assigned female at birth, but some cases may be misdiagnosed and assigned male, potentially inducing fertility, gender identity, and sexual behavior issues in adulthood. In these patients, the benefits and risks of a late gender transition should be carefully evaluated. In this paper, we reviewed the literature concerning the most interesting peculiarities of these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Endocrinology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Fondazione Policlinico "A. Gemelli" IRCCS, I- 00168 Rome, Italy.
- Unit of Endocrine Surgery, Ospedale Isola Tiberina-Gemelli Isola, I-00186 Rome, Italy.
- Departmental Faculty of Medicine, Unicamillus-Saint Camillus International University of Health Sciences, I-00131 Rome, Italy.
ORCID-Profile: Gianluca Cera, Andrea Corsello, Roberto Novizio, Pietro Locantore
Zitieren
APA
Cera, G., Corsello, A., Novizio, R., Di Donna, V., Locantore, P., & Paragliola, R. M. (2024). Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111779
Vancouver
Cera G, Corsello A, Novizio R, Di Donna V, Locantore P, Paragliola RM. Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111779
BibTeX
@article{Cera2024,
author = {Cera, Gianluca and Corsello, Andrea and Novizio, Roberto and Di Donna, Vincenzo and Locantore, Pietro and Paragliola, Rosa Maria},
title = {Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111779}
}
EUVIMED